Prostate cancer is an appropriate target for primary chemoprevention because of its ubiquity, disease-related mortality, treatment-related morbidity, and long latency period. The PCPT and REDUCE trials demonstrate that this cancer…
Successful and accurate imaging of prostate cancer is integral to its clinical management from detection and staging to subsequent monitoring. Various modalities are used including ultrasound, computed tomography, and magnetic…
The debate about the usefulness of population-based prostate cancer screening has been ongoing for decades. The most current evidence shows limited benefit of population screening, and significant psychological, physical and…
